List of bibliographic references
Number of relevant bibliographic references: 11.
| Ident. | Authors (with country if any) | Title |
|---|
| 000058 (2020) |
Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Nami Okamoto [Japon] ; Takahiro Yasumi [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Yuka Okura [Japon] ; Noriko Kinjo [Japon] ; Tomohiro Kubota [Japon] ; Yasuo Nakagishi [Japon] ; Kenichi Nishimura [Japon] ; Mariko Mohri [Japon] ; Masato Yashiro [Japon] ; Junko Yasumura [Japon] ; Hiroyuki Wakiguchi [Japon] ; Masaaki Mori [Japon] | Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis |
| 000889 (2019) |
Ryuhei Yasuoka [Japon] ; Naomi Iwata [Japon] ; Naoki Abe [Japon] ; Toaki Kohagura [Japon] ; Haruna Nakaseko [Japon] ; Masaki Shimizu [Japon] ; Shinji Kawabe [Japon] | Risk factors for hypersensitivity reactions to tocilizumab introduction in systemic juvenile idiopathic arthritis. |
| 002400 (2014) |
Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto | Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan. |
| 002640 (2014) |
Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto | Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan |
| 002816 (2013) |
Jun-Ichi Kawada [Japon] ; Yoshiro Kitagawa ; Naomi Iwata ; Yoshinori Ito | Clinical characteristics of influenza virus infection in juvenile idiopathic arthritis patients treated with tocilizumab. |
| 002871 (2013) |
Shumpei Yokota [Japon] ; Tomoyuki Imagawa [Japon] ; Masaaki Mori [Japon] ; Takako Miyamae [Japon] ; Syuji Takei [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Takuji Murata [Japon] ; Mari Miyoshi [Japon] ; Minako Tomiita [Japon] ; Norihiro Nishimoto [Japon] ; Tadamitsu Kishimoto [Japon] | Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan |
| 003483 (2012) |
Tomoyuki Imagawa [Japon] ; Shumpei Yokota ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Hiroyuki Imanaka ; Yasuhito Nerome ; Naomi Iwata ; Takuji Murata ; Mari Miyoshi ; Norihiro Nishimoto ; Tadamitsu Kishimoto | Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis. |
| 003497 (2012) |
Jun-Ichi Kawada [Japon] ; Naomi Iwata ; Yoshiro Kitagawa ; Hiroshi Kimura ; Yoshinori Ito | Prospective monitoring of Epstein-Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab. |
| 003723 (2012) |
Tomoyuki Imagawa [Japon] ; Syuji Takei [Japon] ; Hiroaki Umebayashi [Japon] ; Kenichi Yamaguchi [Japon] ; Yasuhiko Itoh [Japon] ; Toshinao Kawai [Japon] ; Naomi Iwata [Japon] ; Takuji Murata [Japon] ; Ikuo Okafuji [Japon] ; Mari Miyoshi [Japon] ; Yasuhiro Onoe [Japon] ; Yoshifumi Kawano [Japon] ; Noriko Kinjo [Japon] ; Masaaki Mori [Japon] ; Neelufar Mozaffarian [États-Unis] ; Hartmut Kupper [Allemagne] ; Sourav Santra [Inde] ; Gina Patel [États-Unis] ; Shinichi Kawai [Japon] ; Shumpei Yokota [Japon] | Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan |
| 004159 (2008) |
Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Yukoh Aihara ; Shuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto | Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. |
| 004233 (2008) |
Tim Bongartz [États-Unis] ; Shumpei Yokota [Japon] ; Tomoyuki Imagawa [Japon] ; Masaaki Mori [Japon] ; Takako Miyamae [Japon] ; Yukoh Aihara [Japon] ; Shuji Takei [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Takuji Murata [Japon] ; Mari Miyoshi [Japon] ; Minako Tomiita [Japon] ; Norihiro Nishimoto [Japon] ; Tadamitsu Kishimoto [Japon] | Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis : a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Commentary |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "Naomi Iwata"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i \
-Sk "Naomi Iwata" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Main
|étape= Merge
|type= indexItem
|index= Author.i
|clé= Naomi Iwata
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
